STAT
JANUARY 13, 2025
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5
pharmaphorum
SEPTEMBER 6, 2021
If appropriately implemented, blockchain-based medical records systems of tomorrow could be far more accurate, secure and accessible than the one-size-fits-all approach applied to today’s electronic health records, all while putting additional power back in the hands of the patients. The state of medical records today.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 15, 2023
Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. While this process is essential, it’s also slow, expensive and unpredictable.
European Pharmaceutical Review
AUGUST 23, 2022
“At BUSPH, we have been working with our VA colleagues to look at PTSD symptom improvement in routine care using medical records for several years,” said Jaimie Gradus, Associate Professor of Epidemiology at BUSPH and co-principal investigator on the study.
European Pharmaceutical Review
DECEMBER 14, 2023
as a sector we need to stop working in silos and develop an integrated and more comprehensive approach to evidence-based decision-making in safeguarding public health” Evidence from observational studies is key to understanding the effectiveness and safety 3 of medicines and vaccines in the real world. As of October 2023, 62.93
Pharmacy Is Right For Me
APRIL 4, 2023
There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! Another unique aspect of this model is that all interprofessional team members can access and document within a universal electronic medical record (EPIC).
Syner-G
JULY 7, 2023
Future growth will be driven by factors that include payers mandating the use of such diagnostics, increased understanding of drug safety, advancements in quality of diagnostic testing, and more informed and proactive consumers. Drug development companies must embrace new technology.
Expert insights. Personalized for you.
339 
Let's personalize your content